Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 12.190 | 12.200 | 0.010 |
Stocks | 88.080 | 88.080 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.528 | 17.692 |
Price to Book | 3.660 | 2.835 |
Price to Sales | 2.101 | 2.016 |
Price to Cash Flow | 12.540 | 11.625 |
Dividend Yield | 1.780 | 2.115 |
5 Years Earnings Growth | 11.933 | 10.947 |
Name | Net % | Category Average |
---|---|---|
Technology | 27.910 | 21.951 |
Consumer Cyclical | 21.210 | 10.648 |
Healthcare | 14.320 | 14.349 |
Industrials | 11.210 | 12.117 |
Consumer Defensive | 8.670 | 8.449 |
Communication Services | 5.960 | 7.297 |
Basic Materials | 4.660 | 4.376 |
Financial Services | 3.790 | 15.485 |
Utilities | 1.300 | 2.587 |
Energy | 0.920 | 4.038 |
Real Estate | 0.040 | 2.805 |
Number of long holdings: 84
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Alphabet C | US02079K1079 | 2.13 | 173.96 | +0.21% | |
Eli Lilly | US5324571083 | 1.91 | 820.34 | +0.65% | |
Microsoft | US5949181045 | 1.89 | 415.13 | +0.23% | |
Saint Gobain | FR0000125007 | 1.84 | 80.58 | -0.57% | |
Amazon.com | US0231351067 | 1.81 | 176.44 | -1.60% | |
Novo Nordisk B | DK0062498333 | 1.78 | 927.3 | +1.13% | |
Apple | US0378331005 | 1.76 | 192.25 | +0.54% | |
Marriott Int | US5719032022 | 1.71 | 231.17 | +0.97% | |
Salesforce Inc | US79466L3024 | 1.70 | 234.44 | +7.54% | |
Palo Alto Networks | US6974351057 | 1.67 | 294.91 | +0.57% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PTYESALM0007 | 57.4M | 0.32 | -2.24 | 3.40 | ||
PTYESYLM0009 | 38.6M | 19.29 | 15.93 | 2.35 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review